Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
1.310
+0.040 (3.15%)
At close: Apr 2, 2025, 4:00 PM
1.360
+0.050 (3.82%)
After-hours: Apr 2, 2025, 4:35 PM EDT

SONN Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Apr '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2018 - 2019
Market Capitalization
44573535
Upgrade
Market Cap Growth
-17.79%-13.25%-30.09%-79.64%0.50%-
Upgrade
Enterprise Value
-11-222932
Upgrade
Last Close Price
1.276.6922.92258.721493.186332.48
Upgrade
PS Ratio
1.32233.5833.9320.5072.86-
Upgrade
PB Ratio
0.95-8.96-22.19-2.831.5811.61
Upgrade
P/TBV Ratio
1.09---1.5811.61
Upgrade
EV/Sales Ratio
4.3750.81-6.3560.68-
Upgrade
Debt / Equity Ratio
0.03-0.27-0.90-0.100.010.12
Upgrade
Asset Turnover
0.160.010.030.020.03-
Upgrade
Quick Ratio
1.770.280.550.464.121.56
Upgrade
Current Ratio
2.150.660.860.664.301.62
Upgrade
Return on Equity (ROE)
-285.35%---301.42%-197.66%-27822.18%
Upgrade
Return on Assets (ROA)
-133.99%-180.62%-208.63%-106.50%-84.78%-270.89%
Upgrade
Return on Capital (ROIC)
-242.88%---184.48%-121.74%-2921.10%
Upgrade
Earnings Yield
-242.19%-170.95%-375.53%-414.34%-70.90%-69.20%
Upgrade
FCF Yield
-216.42%-197.85%-425.56%-387.18%-64.01%-44.75%
Upgrade
Buyback Yield / Dilution
-336.81%-404.96%-425.71%---
Upgrade
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q